Newly approved drug is a “game changer” for Stage 4 pancreatic cancer patients Central Oregon DailyFDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJFDA Approves RASONQUE™ (daraxonrasib) Pancreatic Cancer Action NetworkAs RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the ground Fierce PharmaNew Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many The New York Times